STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials

In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in drug discovery, and other health AI news.
Have a take on this story? Discuss it on Gab — no account needed to read, free to join to post.
Discuss on GabWant a second read? Ask Gab AI to analyze this story — private, no account needed to start.
Ask Gab AI💡 AI analysis provides alternative perspectives on current events